The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients Yutaka ShimazuJunya KandaMasayuki Hino Research Open access 17 May 2024 Article: 135
The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study Xiaoyan YinXinchao LiuXiangjiao Meng Research Open access 17 May 2024 Article: 134
Effect of radiochemotherapy on peripheral immune response in glioblastoma LĂ©a HampeSusy DaumoineMarion Thibaudin Research Open access 16 May 2024 Article: 133
The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis Ji-Bin LiMing-Yu LaiMiao-Zhen Qiu Research Open access 16 May 2024 Article: 132
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration Wenjing ZhaoZiwei LiangJiannan Yao Research Open access 15 May 2024 Article: 131
circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3/m6A/PD-L1 manner Zhiling ZhangWenjie HuoJie Li Research Open access 15 May 2024 Article: 130
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer Fenbao LianHaitao YangBaosong Xie Research Open access 14 May 2024 Article: 129
Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype Hongxu LiuMaojin YaoJiaoyan Ren Research Open access 14 May 2024 Article: 128
Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment Peng ZhangYi WanChengsheng Zhang Research Open access 13 May 2024 Article: 127
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study Tatsuki IkomaToshihiko MatsumotoTakayasu Kurata Research Open access 11 May 2024 Article: 126
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis Ya-Nan JinMeng-Yun QiangJi-Jin Yao Research Open access 11 May 2024 Article: 125
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study Shengxiang RenAnwen XiongCaicun Zhou Research Open access 10 May 2024 Article: 124
Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score Chaoting ZhangShance LiZheming Lu Brief Report Open access 10 May 2024 Article: 123
Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma Xin WuTao MiDawei He Research Open access 07 May 2024 Article: 122
Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy Jia-Lin FengBo LiangJun Chen Research Open access 07 May 2024 Article: 121
Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study Song GuanJifeng SunLujun Zhao Research Open access 07 May 2024 Article: 120
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer Panpan ZhangZhendong ChenLin Shen Research Open access 07 May 2024 Article: 119
Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy Barbara Bailly-CailléRomain LevardJean-Matthieu L’Orphelin Brief Report Open access 07 May 2024 Article: 118
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer Yansong LiuMingcui LiFei Ma Research Open access 07 May 2024 Article: 117
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data Justin C. MoserShailender BhatiaJeffrey Weber Research Open access 07 May 2024 Article: 116